Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome Study
Open Access
- 19 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12
Abstract
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are well-known neuronal degenerative disorders that share common pathological events. Approved medications alleviate symptoms but do not address the root cause of the disease. Energy dysfunction in the neuronal population leads to various pathological events and ultimately results in neuronal death. Identifying common therapeutic targets for these disorders may help in the drug discovery process. The Brodmann area 9 (BA9) region is affected in both the disease conditions and plays an essential role in cognitive, motor, and memory-related functions. Analyzing transcriptome data of BA9 provides deep insights related to common pathological pathways involved in AD and PD. In this work, we map the preprocessed BA9 fastq files generated by RNA-seq for disease and control samples with reference hg38 genomic assembly and identify common variants and differentially expressed genes (DEG). These variants are predominantly located in the 3′ UTR (non-promoter) region, affecting the conserved transcription factor (TF) binding motifs involved in the methylation and acetylation process. We have constructed BA9-specific functional interaction networks, which show the relationship between TFs and DEGs. Based on expression signature analysis, we propose that MAPK1, VEGFR1/FLT1, and FGFR1 are promising drug targets to restore blood-brain barrier functionality by reducing neuroinflammation and may save neurons.Keywords
This publication has 90 references indexed in Scilit:
- Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer’s diseaseBMC Medical Genomics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Oxidative stress and cerebral endothelial cells: Regulation of the blood–brain-barrier and antioxidant based interventionsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2Annals of Neurology, 2011
- HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variantsNucleic Acids Research, 2011
- PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseScience Translational Medicine, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neuronsProceedings of the National Academy of Sciences, 2008
- Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampusGenomics, 2007
- Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomesGenome Research, 2005